HLA I类下调的衰老表皮基底细胞在皮肤型红斑狼疮皮肤病理中的协调作用
本研究利用皮肤型红斑狼疮(CLE)患者皮肤样本及系统性红斑狼疮(SLE)小鼠模型,探讨衰老表皮基底细胞在CLE发病中的作用。研究发现p21WAF1/CIP1高表达衰老表皮基底细胞高表达I型干扰素并增强周围正常表皮基底细胞HLA-I表达,同时通过上调EGFR信号下调自身HLA-I以逃避免疫监视,促进CD8阳性T细胞介导的正常表皮基底细胞毒性。药物清除衰老细胞可改善SLE样皮肤病变。
要点
- CLE患者p21WAF1/CIP1高表达衰老表皮基底细胞高表达I型干扰素。
- 衰老表皮细胞通过EGFR信号上调下调HLA-I表达以逃避免疫监视。
- 药物清除衰老表皮基底细胞可改善SLE小鼠模型皮肤病变。
核心结论
- 衰老细胞在CLE患者中形成微环境,引导细胞毒性T细胞介导针对正常表皮的应答,参与疾病病理。
- 靶向衰老细胞及其信号通路可能为CLE和SLE皮肤病变患者提供新的治疗策略。
研究设计与样本
- 研究使用CLE患者皮肤样本和SLE小鼠模型,进行细胞衰老谱分析及体外实验。
- 使用NCBI GEO数据库数据集GSE184989(CLE,n=68;对照,n=4)和GSE186476单细胞RNA测序数据(CLE,n=7;对照,n=14),以及Accelerating Medicines Partnership(AMP)Phase 1-Metro(SLE,n=17)。
- 体外实验检测p21WAF1/CIP1、I型干扰素(IFN)、HLA I类(HLA-I)和表皮生长因子受体(EGFR)信号表达。
- 在SLE小鼠模型中使用衰老细胞清除药物非瑟酮进行药理学清除衰老细胞。
主要发现
- CLE患者p21WAF1/CIP1高表达衰老表皮基底细胞 exhibit 高I型IFN表达。
- 这些衰老细胞增强周围正常表皮基底细胞的IFN信号,导致HLA-I表达增加。
- 衰老表皮细胞上调EGFR信号,下调HLA-I表达,使其逃避免疫监视。
- HLA-I表达的异质性促进CD8阳性T细胞介导对正常表皮基底细胞的毒性,导致其凋亡。
- 药理学清除衰老表皮基底细胞改善SLE样皮肤病变。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This study investigates the role of senescent epidermal basal cells in cutaneous lupus erythematosus (CLE) pathogenesis using skin samples from patients with CLE and a mouse model of systemic lupus erythematosus (SLE). METHODS: Cellular senescence profiling used datasets from the NCBI GEO database and Accelerating Medicines Partnership (AMP) Phase 1-Metro. Gene array data from GSE184989 (CLE, n = 68; control, n = 4), single-cell RNA sequencing data from GSE186476 (CLE, n = 7; control, n = 14), and AMP Phase 1-Metro (SLE, n = 17) were used. In vitro experiments further examined the expression of p21WAF1/CIP1, Type I interferon (IFN), HLA class I (HLA-I), and epidermal growth factor receptor (EGFR) signaling. Pharmacological clearance of senescent cells was performed using the senolytic drug fisetin in the SLE mouse model. RESULTS: p21WAF1/CIP1-high senescent epidermal basal cells in patients with CLE exhibit high Type I IFN expression. These cells enhance IFN signaling in surrounding normal epidermal basal cells, leading to increased HLA-I expression. In contrast, senescent epidermal cells up-regulate epidermal growth factor receptor signaling, which downregulates HLA-I expression, allowing them to evade immune surveillance. This heterogeneity of HLA-I expression promotes CD8-positive T-mediated toxicity against normal epidermal basal cells, resulting in their apoptosis. Pharmacological clearance of senescent epidermal basal cells improved SLE-like skin lesions. CONCLUSION: Senescent cells create a microenvironment that directs cytotoxic T cell-mediated responses against normal epidermis in patients with CLE, contributing to disease pathology. Targeting senescent cells and their signaling pathways may offer novel therapeutic strategies for patients with skin lesions from CLE and SLE.
引用
- Yamamoto S, Saito Y, Sato T, et al. Orchestration of Skin Pathology in Cutaneous Lupus Erythematosus by HLA Class I Down-Regulated Senescent Epidermal Basal Cells. Arthritis Rheumatol. 2025. PMID: 40386939. doi:10.1002/art.43244
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。